)
Dr. Ilse Roodink
Chief Scientific Officer,
Immunoprecise Antibodies
Dr. Ilse Roodink, Chief Scientific Officer (CSO) of IPA, supports the company’s global R&D teams. Previously, she held scientific roles at IPA’s Dutch facility in Oss and served as Scientific Director of IPA Europe, where she managed contract research projects and integrated innovative antibody characterization and engineering technologies. Dr. Roodink holds a Master's Degree in Biomedical Health Sciences and a Ph.D. in Medical Sciences from Radboud University, Nijmegen. Her research, published in peer-reviewed journals, focused on platform development for discovering antibodies against natively folded tumor targets